| My rules of a perfect SAPIEN™ transcatheter aortic valve implantation. | |
| | |
MedLine Citation:
|
PMID: 22322575 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Transcatheter aortic valve implantation has been established as an alternative treatment option for those patients with aortic stenosis (AO), who are high risk or unsuitable for surgical aortic valve replacement. Since its introduction, transcatheter aortic valve implantation has been mainly performed either by a percutaneous approach through the femoral arteries or by using a transapical approach via a left-sided mini-thoracotomy. More recently, experience on alternative access routes such as the subclavian artery and the ascending aorta has been reported in a small number of patients. The Edwards SAPIENTM transcatheter heart valve (Edwards Lifesciences, Irvine, CA, USA) was the first balloon-expandable transcatheter heart valve to receive CE-Mark certification in Europe for transfemoral and transapical aortic valve implantation in 2007/2008. However, it also has been used for transcatheter procedures using access through ascending aorta and subclavian artery. Appropriate patient selection is key for a successful transcatheter aortic valve program and should be in the responsibility of the heart team of interventional cardiologists, cardiac surgeons, cardiac imaging specialists, anesthetists and geriatrists. Their mixture of skills will enable the team to build patient care pathways in which patients are assessed regarding cardiac and non-cardiac comorbidities, the most appropriate type of treatment is jointly agreed, and finally various treatment options are delivered. In this review we highlight the cornerstones of a successful transcatheter aortic valve program using the Edwards SAPIENTM valve. We focus in particular on preoperative diagnostics, patient selection and potential strengths and weaknesses of the various access routes to offer a guideline for future experience. |
| | |
Authors:
|
R Dworakowski; O Wendler |
Related Documents
:
|
22477395 - An update on the 'fast-track' abdominal aortic aneurysm repair. 22324785 - Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody t... 20833255 - Key role of the rhoa/rho kinase system in pulmonary hypertension. 11732535 - Acute right-to-left inter-atrial shunt; an important cause of profound hypoxia. 11680535 - A carotid stenosis model in canines. 16003265 - Myocardial contrast echocardiography assessment of acute changes in collateral perfusio... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Minerva cardioangiologica Volume: 60 ISSN: 0026-4725 ISO Abbreviation: Minerva Cardioangiol Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-02-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0400725 Medline TA: Minerva Cardioangiol Country: Italy |
Other Details:
|
Languages: eng Pagination: 71-83 Citation Subset: IM |
Affiliation:
|
Department of Cardiothoracic Surgery, King's College Hospital, King's Health Partners, London, UK - olaf.wendler@nhs.net. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Update on percutaneous mitral valve therapy: clinical results and real life experience.
Next Document: Review of the MitraClip clinical evidence.